ARVINAS INC (ARVN) Fundamental Analysis & Valuation

NASDAQ:ARVN • US04335A1051

Current stock price

10.1 USD
-0.22 (-2.13%)
Last:

This ARVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ARVN Profitability Analysis

1.1 Basic Checks

  • ARVN had negative earnings in the past year.
  • In the past year ARVN has reported a negative cash flow from operations.
  • In the past 5 years ARVN always reported negative net income.
  • In the past 5 years ARVN reported 4 times negative operating cash flow.
ARVN Yearly Net Income VS EBIT VS OCF VS FCFARVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • ARVN has a better Return On Assets (-11.26%) than 66.32% of its industry peers.
  • ARVN's Return On Equity of -18.62% is fine compared to the rest of the industry. ARVN outperforms 69.95% of its industry peers.
Industry RankSector Rank
ROA -11.26%
ROE -18.62%
ROIC N/A
ROA(3y)-19.21%
ROA(5y)-18.39%
ROE(3y)-36.56%
ROE(5y)-36.83%
ROIC(3y)N/A
ROIC(5y)N/A
ARVN Yearly ROA, ROE, ROICARVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K

1.3 Margins

  • ARVN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARVN Yearly Profit, Operating, Gross MarginsARVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ARVN Health Analysis

2.1 Basic Checks

  • ARVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ARVN has been reduced compared to 1 year ago.
  • ARVN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ARVN has a worse debt to assets ratio.
ARVN Yearly Shares OutstandingARVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ARVN Yearly Total Debt VS Total AssetsARVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.98, we must say that ARVN is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.98, ARVN perfoms like the industry average, outperforming 48.19% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that ARVN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.00, ARVN is in the better half of the industry, outperforming 62.69% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.98
ROIC/WACCN/A
WACC9.5%
ARVN Yearly LT Debt VS Equity VS FCFARVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 4.92 indicates that ARVN has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.92, ARVN is in the better half of the industry, outperforming 64.77% of the companies in the same industry.
  • A Quick Ratio of 4.92 indicates that ARVN has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 4.92, ARVN is doing good in the industry, outperforming 66.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.92
Quick Ratio 4.92
ARVN Yearly Current Assets VS Current LiabilitesARVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ARVN Growth Analysis

3.1 Past

  • ARVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.79%, which is quite impressive.
  • ARVN shows a decrease in Revenue. In the last year, the revenue decreased by -0.30%.
  • Measured over the past years, ARVN shows a very strong growth in Revenue. The Revenue has been growing by 64.50% on average per year.
EPS 1Y (TTM)53.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.6%
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y25.96%
Revenue growth 5Y64.5%
Sales Q2Q%-83.95%

3.2 Future

  • ARVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.85% yearly.
  • ARVN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.58% yearly.
EPS Next Y-161.62%
EPS Next 2Y-62.58%
EPS Next 3Y-24.76%
EPS Next 5Y14.85%
Revenue Next Year-68.62%
Revenue Next 2Y-49.04%
Revenue Next 3Y-17.96%
Revenue Next 5Y-0.58%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ARVN Yearly Revenue VS EstimatesARVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
ARVN Yearly EPS VS EstimatesARVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

0

4. ARVN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ARVN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARVN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARVN Price Earnings VS Forward Price EarningsARVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARVN Per share dataARVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ARVN's earnings are expected to decrease with -24.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.58%
EPS Next 3Y-24.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARVN Dividend Analysis

5.1 Amount

  • No dividends for ARVN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARVN Fundamentals: All Metrics, Ratios and Statistics

ARVINAS INC

NASDAQ:ARVN (3/24/2026, 2:31:01 PM)

10.1

-0.22 (-2.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-24
Earnings (Next)04-29
Inst Owners88.37%
Inst Owner Change-18.2%
Ins Owners1.06%
Ins Owner Change2.79%
Market Cap646.00M
Revenue(TTM)262.60M
Net Income(TTM)-80.80M
Analysts76.15
Price Target13.68 (35.45%)
Short Float %7.29%
Short Ratio5.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.97%
Min EPS beat(2)-82.67%
Max EPS beat(2)40.73%
EPS beat(4)3
Avg EPS beat(4)48.54%
Min EPS beat(4)-82.67%
Max EPS beat(4)218.09%
EPS beat(8)7
Avg EPS beat(8)42.7%
EPS beat(12)9
Avg EPS beat(12)24.85%
EPS beat(16)9
Avg EPS beat(16)12.59%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-73.3%
Max Revenue beat(2)74.06%
Revenue beat(4)2
Avg Revenue beat(4)79.52%
Min Revenue beat(4)-73.3%
Max Revenue beat(4)345.02%
Revenue beat(8)4
Avg Revenue beat(8)48.53%
Revenue beat(12)6
Avg Revenue beat(12)23.66%
Revenue beat(16)9
Avg Revenue beat(16)23.16%
PT rev (1m)1.33%
PT rev (3m)4.59%
EPS NQ rev (1m)-19.23%
EPS NQ rev (3m)-16.28%
EPS NY rev (1m)-12.62%
EPS NY rev (3m)-9.12%
Revenue NQ rev (1m)-12.76%
Revenue NQ rev (3m)-12.62%
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-4.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.46
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)-1.28
EYN/A
EPS(NY)-3.35
Fwd EYN/A
FCF(TTM)-4.31
FCFYN/A
OCF(TTM)-4.28
OCFYN/A
SpS4.11
BVpS6.78
TBVpS6.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.26%
ROE -18.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.21%
ROA(5y)-18.39%
ROE(3y)-36.56%
ROE(5y)-36.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.33%
Cap/Sales 0.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.92
Quick Ratio 4.92
Altman-Z -0.98
F-Score5
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)54.29%
Cap/Depr(5y)73.75%
Cap/Sales(3y)1.7%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.6%
EPS Next Y-161.62%
EPS Next 2Y-62.58%
EPS Next 3Y-24.76%
EPS Next 5Y14.85%
Revenue 1Y (TTM)-0.3%
Revenue growth 3Y25.96%
Revenue growth 5Y64.5%
Sales Q2Q%-83.95%
Revenue Next Year-68.62%
Revenue Next 2Y-49.04%
Revenue Next 3Y-17.96%
Revenue Next 5Y-0.58%
EBIT growth 1Y53.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-129.77%
EBIT Next 3Y-23.76%
EBIT Next 5YN/A
FCF growth 1Y-5.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.59%
OCF growth 3YN/A
OCF growth 5YN/A

ARVINAS INC / ARVN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARVINAS INC (ARVN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ARVN.


Can you provide the valuation status for ARVINAS INC?

ChartMill assigns a valuation rating of 0 / 10 to ARVINAS INC (ARVN). This can be considered as Overvalued.


Can you provide the profitability details for ARVINAS INC?

ARVINAS INC (ARVN) has a profitability rating of 1 / 10.


What is the expected EPS growth for ARVINAS INC (ARVN) stock?

The Earnings per Share (EPS) of ARVINAS INC (ARVN) is expected to decline by -161.62% in the next year.